Neuro-Oncology Reviews
Volume
27 Number 27
30 September 2025
Home > Publications > Neuro-Oncology Reviews > Volume 27, Year 2025 > Number 27, 30 September
Rana A, Mittal A, Vashist C, Sharma S, Rajput S, Sridhar SB,
Malviya R.
Nanoparticle-Based
Approaches for Glioblastoma Treatment: Advances and Future
Prospects.
CNS
Neurol Disord Drug Targets. 2025 Sep 22. doi:
10.2174/0118715273386112250912172648. PMID:
40993928. Review˰
ˍ
Motiei-Langroudi R.
Genetic Markers
and Mutations in Primary Spinal Cord Tumors and Their Impact on
Clinical Management.
Brain
Sci. 2025 Sep 23;15(10):1028. doi:
10.3390/brainsci15101028. PMID:
41154124. Review. ˍ
Reitman ZJ, Fan Y.
Authors' View-FLASH
Radiation: A Game-Changer in Pediatric Brain Tumor Treatment?
Int
J Radiat Oncol Biol Phys. 2025 Sep 23;123(3):848-851.
doi:
10.1016/j.ijrobp.2025.04.036. PMID:
40998483. Editorial˰
ˍ
Bruno F, Pellerino A, Pronello E, Rudà R.
Rare
gliomas: standard treatment approaches and new target therapies.
Curr
Opin Neurol. 2025 Sep 25. doi:
10.1097/WCO.0000000000001428. PMID:
40990677. Review˰
ˍ
Kotch C, Green K, Fisher MJ, Hargrave D.
Pediatric-Type
Diffuse Low Grade Glioma.
Adv
Cancer Res. 2025 Sep 25;167:1-35. doi:
10.1016/bs.acr.2025.08.006. PMID:
41198334. Review˰
ˍ
Jiang S, Zhong C.
Glioma drug
development benefits from emerging phase 0 and
window-of-opportunity trial paradigm.
Cell
Commun Signal. 2025 Sep 25;23(1):399. doi:
10.1186/s12964-025-02408-4. PMID:
40999453. Review. ˍ
Pan XH, Wang N, He YC, Su J, Gao YF.
Scientometric
analysis of glioblastoma and blood-brain barrier research
(1995-2024): evolving trends and therapeutic challenges.
Front
Oncol. 2025 Sep 25;15:1649414. doi:
10.3389/fonc.2025.1649414. PMID:
41079104. Bibliometric analysis. ˍ
Vasquez JC, Bindra RS, Gueble SE.
Novel
Strategies for Improved Treatment of O6-Methylguanine-DNA
Methyltransferase Promoter-Methylated Glioma.
Med
Res Arch. 2025 Sep 25;13(9):10.18103/mra.v13i9.6944.
doi:
10.18103/mra.v13i9.6944. PMID:
41169667. Review. ˍ
Zhang C, Zhang H, Cao J, Liu M.
Neuroscience
in glioma biology (Review).
Oncol
Rep. 2025 Sep 25;54(6):166. doi:
10.3892/or.2025.8999. PMID:
40999988. Review. ˍ
Liu S, Liang R.
Oncolytic Virotherapy
for Glioma: A Bibliometric Roadmap for Multidisciplinary Clinical
and Research Strategies.
J
Multidiscip Healthc. 2025 Sep 26;18:6167-6185. doi:
10.2147/JMDH.S557248. PMID:
41040426. Bibliometric analysis. ˍ
Patel KD, Persaud NA, Rama S.
Therapeutic
Outcomes and Toxicity Mitigation of Proton Beam Therapy in
Pediatric Neuro-Oncology: A Systematic Review.
Cureus.
2025 Sep 26;17(9):e93290. doi:
10.7759/cureus.93290. PMID:
41146828. Review. ˍ
Scarpitta R, Cappello E, Cangialosi A, Gori V, Luca G, Gori G,
Bocci G.
Pharmacological Phase I
Clinical Trials in Pediatric Brain Tumors (1990-2024): A
Historical Perspective.
Oncol
Res. 2025 Sep 26;33(10):2603-2656. doi:
10.32604/or.2025.066260. PMID:
41050069. Review.
ˍ
Tremante E, Díaz Méndez AB, Rizzo MG.
The
Role of LncRNAs in Radio- and Chemoresistance of Glioblastoma:
Prognostic or Therapeutic?
Curr
Oncol. 2025 Sep 27;32(10):539. doi:
10.3390/curroncol32100539. PMID:
41149459. Review. ˍ
Li J, Lu L, Duan Y, Huang G, Fang X, Deng Y, Tang F, Jiang F, Dai
D.
Global research trends in CAR-T
cell therapy for glioblastoma: a bibliometric and visualized
analysis.
Discov
Oncol. 2025 Sep 29;16(1):1770. doi:
10.1007/s12672-025-03285-6. PMID:
41021151. Bibliometric analysis. ˍ
Yazgan SC, Yekedüz E, Akkuş E, Sun M, Gillessen S,
Fizazi K, McKay RR, Ay C, Castro E, Agarwal N, Choueiri TK, Ürün
Y. Venous thromboembolic event risk with
PARP inhibitors in solid tumors: a systematic review and
meta-analysis.
ESMO
Open. 2025 Sep 29;10(10):105811. doi:
10.1016/j.esmoop.2025.105811. PMID:
41027069. Review; Meta-analysis. ˍ
Schurr A.
Glioma neuron symbiosis: a
hypothesis.
Front
Neurosci. 2025 Sep 30;19:1646148. doi:
10.3389/fnins.2025.1646148. PMID:
41098857. Perspective. ˍ